Overview of the Industry: A World of Opportunities

The time is ripe to further a pharmaceutical career in the United States. The industry is full of promising opportunities for people eager to contribute and advance.

Articles in this issue

over 24 years ago

Article

I Have A Dream: Communicating a Vision Helps Managers Become Leaders

over 24 years ago

Article

On the Right Path: Sales Careers in Pharma

over 24 years ago

Article

Surviving a Merger: HBA Takes a Look

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

Image Credit: Adobe Stock Images/OlegKachura. From a distance, the first 15 CNPV awards look like a policy experiment in speeding up reviews. Up close, they are something more: a sorting mechanism that rewards early movers in operating model transformation, not just drug discovery.

Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers

ByThani Jambulingam, PhD

November 19th 2025

Christopher Stanton, Ph.D., Marvin Bower Associate Professor of Business Administration at Harvard Business School.

How Can Harvard Business School Students and Alumni Prepare for Their Long-Term Career Journeys in an Accelerating AI-Focused Society?

ByMichael Wong

November 17th 2025

Roundup: Ovid Therapeutics and Metagenomi Announce 2025 Third Quarter Results and Leadership Updates

ByNicholas Jacobus

November 13th 2025

HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research

ByNicholas Jacobus

November 12th 2025

Bob Mauch: Strengthening the Chain

ByMike Hollan

October 21st 2025

Overview of the Industry: A World of Opportunities

Articles in this issue

Newsletter

Related Content

Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers

How Can Harvard Business School Students and Alumni Prepare for Their Long-Term Career Journeys in an Accelerating AI-Focused Society?

Roundup: Ovid Therapeutics and Metagenomi Announce 2025 Third Quarter Results and Leadership Updates

HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research

Bob Mauch: Strengthening the Chain

Trending on PharmExec

Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients

Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths

Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint

Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products

How Will the Inclusion of GLP-1s in Medicaid and Medicare Impact Businesses?